Pliant Therapeutics, Inc. · NASDAQ:PLRX

Citadel Advisors LLC's stake in Pliant Therapeutics, Inc. fell to 3.50% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Citadel Advisors LLC's stake in Pliant Therapeutics, Inc. fell to 3.50%, 2,143,426 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
3.50%
Shares
2,143,426
Intent
Passive
What changed
Fell below 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC2.30%1,418,022
Citadel Advisors Holdings LP2.30%1,418,022
Citadel GP LLC2.30%1,418,022
Citadel Securities LLC1.10%673,114
Citadel Securities Group LP1.20%725,404
Citadel Securities GP LLC1.20%725,404
Kenneth Griffin3.50%2,143,426

Source

View original at SEC

Related